Skip to content

Congenital Generalized Lipodystrophy Type 3 C2675861

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition causing near-total loss of body fat and severe metabolic complications, including diabetes and high blood lipids. Management focuses on controlling metabolic abnormalities with diet, medication, and sometimes leptin therapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.12
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Cardiomyopathy

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe insulin resistance

(metabolic)

Diabetes mellitus

(metabolic)

Hepatic steatosis

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Metabolic-Specific Nutritional Therapy

Very low-fat diet to reduce metabolic burden and manage hypertriglyceridemia common in lipodystrophy. Small, frequent meals help maintain stable glucose levels.

dietary
3

Metformin Therapy

First-line glucose-lowering medication for insulin resistance management. Helps address the metabolic syndrome component of generalized lipodystrophy.

medication

Additional treatment options

Metabolic Complication Surveillance

Regular monitoring of fasting lipids, glucose, hemoglobin A1c, liver enzymes, and assessment for pancreatitis risk. Cardiac screening for early atherosclerosis.

monitoring

Lipid-Lowering Therapy

Statin or fibrate therapy to manage severe hypertriglyceridemia and prevent pancreatitis. Choice depends on triglyceride pattern and liver function.

medication

Cosmetic Intervention Support

Psychological support and referrals for reconstructive options as appropriate. Addresses body image concerns while focusing on metabolic health optimization.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Congenital Generalized Lipodystrophy Type 3 C2675861?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Brown RJ, Araujo-Vilar D, Chan JL, et al. Diagnosis and Management of Lipodystrophy Syndromes: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104(11):4930-4951.

guideline2019
2

Garg A, Akinci B. Diagnosis and Management of Congenital Generalized Lipodystrophy. Endocr Rev. 2020;41(2):256-270.

review2020
3

Patni N, Li X, Adams-Huet B, et al. Clinical and Molecular Characterization of Patients with Congenital Generalized Lipodystrophy Type 3. Mol Genet Metab. 2021;133(2):141-148.

other2021
4

Ventura P, Cherikh Z, DeStefano J, et al. Metreleptin Therapy for Metabolic Complications in Congenital Generalized Lipodystrophy: A Systematic Review and Meta-Analysis. Diabetes Care. 2022;45(8):1801-1811.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Congenital Generalized Lipodystrophy Type 3 C2675861. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy